Mycotoxins testing in cannabis is an essential step in ensuring the safety and quality of cannabis products by reducing the risk of harm to consumers. Mycotoxins testing in cannabis typically involves the following steps:
Sample collection: PPB Analytical Incorporated receives the cannabis samples for testing and verifies the identification and chain of custody for each sample. Samples are taken according to Health Canada guidelines, which specify the minimum number of samples required and the frequency of sampling.
Sample Preparation: Methanol, ethanol, or water are used as solvents to extract samples ground into homogeneous powders. Any plant debris or impurities are then removed from the extracted solution.
Analysis: The filtered extract is then analyzed using advanced analytical techniques such as high-performance liquid chromatography (HPLC) or gas chromatography-mass spectrometry (GC-MS). These techniques are highly sensitive and can detect mycotoxins at very low levels.
Reporting: The results of the analysis are reported in terms of the concentration of each mycotoxin detected in the sample. These results are compared against the maximum levels established by Health Canada.
Next Steps: If mycotoxin levels exceed the maximum levels established by Health Canada, follow-up actions may be necessary, such as disposing of contaminated material or implementing corrective measures.